Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > With the Recent FDA Breakthrough Designation

<< Previous

Bullboard Posts

Next >>

Comment by Gorf79on Jul 19, 2022 11:11am

159 Views

Post# 34834293

RE:RE:RE:RE:RE:RE:RE:With the Recent FDA Breakthrough Designation

Who cares whether they do another financing!?

If you are worried about that load up at these prices.

A parabolic take off is literally a handful of trading days away!

I couldn't care less if they issue an all internal PP for 10 mil.

It is meaningless in the big picture!

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?